Home » Newsletters » BioWorld Science

BioWorld Science

April 7, 2003

View Archived Issues

Integrated pharmacokinetic/pharmacodynamic model developed for SB-480848

Garenoxacin pharmacokinetics similar in healthy and hepatically impaired subjects

Pharmacokinetics, metabolism and excretion of single-dose sitafloxacin in healthy males

Food intake does not alter the pharmacokinetics of multiple-dose lonafarnib

No pharmacokinetic interactions for memantine and donepezil in healthy volunteers

DOV reacquires diltiazem rights from Biovail

Results of argatroban and gpIIb/IIIa inhibitor combination study

Isis outlines 2003/4 milestones

New patent broadens protection for Virulizin

Sumitomo presents new muscarinic M3 antagonists for use in urinary incontinence

Novel PARP inhibitors in early development at Icos

JT researchers prepare and test new HIV integrase inhibitors

New antitumor duocarmycin analogues covered by Medarex patent

Novel sodium channel blockers for pain, seizures and other disorders

E.U. approval for NeoRecormon use once every two weeks for renal anemia

Metvix PDT approved in Australia

Remicade approved for long-term use in fistulizing Crohn's disease

Biosyn acquires rights to HIV microbicide candidate from NIH

AP-5346 enters phase I trials in Europe

Brand name announced for decitabine

Graffinity enters research collaboration with Serono

Ongoing program for clopidogrel in atherosclerosis

HYB-2055 enters the clinic

Water-soluble taxoids for use in tumor-activated prodrugs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...